The Patent Finder

Ohio University

113 patents currently held · Updated Nov 15, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

15
Ending by 2030
Jan 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Nov 19 to 28, 2026 · next Nov 19
  • 2 fees due Dec 11 to 23, 2026 · next Dec 11
  • 1 fee due Jan 30, 2027
    The maintenance fee for Proliferative disease treatment methods with phosphaplatin complexes (US 10,364,264) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
  • 6 fees due Feb 4 to 27, 2027 · next Feb 4
  • 2 fees due Mar 10 to 15, 2027 · next Mar 10
  • 2 fees due Apr 17 to 29, 2027 · next Apr 17
  • 2 fees due May 10 to 21, 2027 · next May 10
  • 3 fees due Jun 1 to 26, 2027 · next Jun 1
  • 3 fees due Jul 2 to 30, 2027 · next Jul 2
  • 3 fees due Aug 4 to 27, 2027 · next Aug 4
  • 3 fees due Sep 3 to 17, 2027 · next Sep 3
  • 4 fees due Oct 2 to 28, 2027 · next Oct 2
  • 2 fees due Nov 7 to 12, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,153,817Synthesis of methyl nonactate derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,700,649Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,034,964Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,653,132Phosphaplatins and their use in pharmaceutical compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,062,382Electrolytic cells and methods for the production of ammonia and hydrogen
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,017,550Exfiltration apparatus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,445,710Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,191,393Micro-channel tubes and apparatus and method for forming micro-channel tubes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,029,759Pretreatment method for the synthesis of carbon nanotubes and carbon nanostructures from coal and carbon chars
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,409,305Pretreatment method for the synthesis of carbon nanotubes and carbon nanostructures from coal and carbon chars
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 113 patents shown.
Pro members see all 113.
Pro members: see all 113 patents
Also on record, not counted in the 113: 2 patents in force now held by others · 71 lapsed for an unpaid fee · 51 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 pending · 4 abandoned · 68 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited